ID

39612

Beschreibung

Study ID: 110852 Clinical Study ID: 110852 Study Title: MD7110852, A Phase 2b Dose-Ranging Study of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01134055 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: pazopanib eye drops, ranibizumab intravitreal injection, placebo Trade Name: pazopanib, ranibizumab Study Indication: Macular Degeneration

Stichworte

Versionen (1)
  1. 03.02.20 03.02.20 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

3. Februar 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration NCT01134055

Englisch

Screen - Re-Screening data; Study Eye; Ranibizumab Injection

1 Formulare  
Re-Screening data
Beschreibung

Re-Screening data

Alias
UMLS CUI-1
C0220908
UMLS CUI-2
C1511726
Was subject re-screened for this trial?
Beschreibung

Was subject re-screened for this trial?

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0220908
UMLS CUI [1,2]
C2347804
If subject was re-screened for this trial, record original Subject Number
Beschreibung

If subject was re-screened for this trial, record original Subject Number

Datentyp

text

Alias
UMLS CUI [1,1]
C0220908
UMLS CUI [1,2]
C2347804
UMLS CUI [2]
C2348585
Study Eye
Beschreibung

Study Eye

Alias
UMLS CUI-1
C0008972
UMLS CUI-2
C0015392
Study Eye Identification
Beschreibung

Study Eye Identification

Datentyp

text

Alias
UMLS CUI [1,1]
C0008972
UMLS CUI [1,2]
C0015392
UMLS CUI [1,3]
C0205396
Ranibizumab Injection
Beschreibung

Ranibizumab Injection

Alias
UMLS CUI-1
C1566537
UMLS CUI-2
C1272883
Date and Time of ranibizumab injection in the study eye
Beschreibung

Date and Time of ranibizumab injection in the study eye

Datentyp

datetime

Alias
UMLS CUI [1,1]
C1566537
UMLS CUI [1,2]
C1272883
UMLS CUI [1,3]
C0011008
UMLS CUI [1,4]
C0040223
UMLS CUI [2,1]
C0008972
UMLS CUI [2,2]
C0015392
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Screen - Re-Screening data; Study Eye; Ranibizumab Injection

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Re-Screening data
C0220908 (UMLS CUI-1)
C1511726 (UMLS CUI-2)
Was subject re-screened for this trial?
Item
Was subject re-screened for this trial?
boolean
C0220908 (UMLS CUI [1,1])
C2347804 (UMLS CUI [1,2])
If subject was re-screened for this trial, record original Subject Number
Item
If subject was re-screened for this trial, record original Subject Number
text
C0220908 (UMLS CUI [1,1])
C2347804 (UMLS CUI [1,2])
C2348585 (UMLS CUI [2])
Item Group
Study Eye
C0008972 (UMLS CUI-1)
C0015392 (UMLS CUI-2)
Item
Study Eye Identification
text
C0008972 (UMLS CUI [1,1])
C0015392 (UMLS CUI [1,2])
C0205396 (UMLS CUI [1,3])
Study Eye Identification
Code List
Study Eye Identification
CL Item
Right (R)
CL Item
Left (L)
Item Group
Ranibizumab Injection
C1566537 (UMLS CUI-1)
C1272883 (UMLS CUI-2)
Date and Time of ranibizumab injection in the study eye
Item
Date and Time of ranibizumab injection in the study eye
datetime
C1566537 (UMLS CUI [1,1])
C1272883 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
C0008972 (UMLS CUI [2,1])
C0015392 (UMLS CUI [2,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video